Drug combination highly effective in children with standard-and high-risk APL

A clinical trial has found that the combination of all-trans retinoic acid, which is a metabolite of vitamin A, and arsenic trioxide is highly effective in children with standard- and high-risk acute promyelocytic leukemia, or APL.

Read more: https://www.news-medical.net/news/20211111/Drug-combination-highly-effective-in-children-with-standard-and-high-risk-acute-promyelocytic-leukemia.aspx